Caption Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,000
| Closed | -$21.9K | – | 516 |
|
|
2025
Q1 | $21.9K | Hold |
15,000
| – | – | ﹤0.01% | 492 |
|
|
2024
Q4 | $32K | Buy |
+15,000
| New | +$32K | ﹤0.01% | 478 |
|
|
2023
Q2 | – | Sell |
-74,900
| Closed | -$370K | – | 362 |
|
|
2023
Q1 | $370K | Buy |
74,900
+59,900
| +399% | +$296K | 0.01% | 202 |
|
|
2022
Q4 | $94.4K | Buy |
+15,000
| New | +$94.4K | ﹤0.01% | 344 |
|
|
2021
Q3 | – | Sell |
-14,600
| Closed | -$380K | – | 528 |
|
|
2021
Q2 | $380K | Buy |
+14,600
| New | +$380K | 0.01% | 288 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 366 |
|
|
2020
Q3 | – | Sell |
-1,400
| Closed | -$60K | – | 347 |
|
|
2020
Q2 | $60K | Sell |
1,400
-10,600
| -88% | -$454K | ﹤0.01% | 267 |
|
|
2020
Q1 | $234K | Sell |
12,000
-6,455
| -35% | -$126K | 0.01% | 204 |
|
|
2019
Q4 | $480K | Buy |
+18,455
| New | +$480K | 0.02% | 176 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 263 |
|